GDC-6599
- Generic Name
- GDC-6599
A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough
Phase 2
Completed
- Conditions
- Chronic Refractory Cough (CRC) With Non-atopic AsthmaCRC With Atopic AsthmaUnexplained Chronic CoughCRC With Chronic Obstructive Pulmonary DiseaseCRC With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
- Interventions
- First Posted Date
- 2022-12-21
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT05660850
- Locations
- 🇦🇺
Box Hill Hospital; Eastern Clinical Research Unit, Box Hill, Victoria, Australia
🇺🇸Southern California Institute For Respiratory, Los Angeles, California, United States
🇬🇧Queen Anne Street Medical Centre, London, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath